Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Biopsy may underestimate prostate cancer in obese and overweight men

28.03.2007
Obese and overweight men who are diagnosed with prostate cancer by biopsy are more likely than healthy weight men to actually have a more aggressive case of the disease than the biopsy results would indicate, according to a study led by a Duke University Medical Center researcher.

The finding suggests that misleading biopsy results may be causing many obese and overweight men to receive inadequate or inappropriate treatment that is not aggressive enough to combat the true nature of their disease, said study leader Stephen Freedland, M.D., an assistant professor in the Division of Urology and the Duke Prostate Center.

"We already know that it’s more difficult to diagnose prostate cancer in obese men because they have lower levels of prostate-specific antigen, or PSA, a common blood marker for prostate cancer, and because their larger-sized prostates make it more likely for a biopsy to miss the cancer," he said. "These findings further suggest that we could be missing even more high-grade disease among obese men."

Gaining a better understanding of links between biopsies and prostate cancer also may help physicians improve patient treatment, said Freedland, who also holds an appointment in surgery at the Durham Veterans Affairs Medical Center.

"If we can determine through additional biopsies that an obese or overweight man has more aggressive prostate cancer, we can discuss whether the cancer should be treated with more than one approach, such as combining hormonal therapy with radiation, to reduce the risk of the cancer spreading and improve the chances of cure," Freedland said. "We must also keep in mind that even if a well-done biopsy shows low-grade cancer in an obese patient, there is still a reasonable likelihood that the patient may have high-grade disease."

The researchers, from six universities, published the findings in the March 2007 issue of the journal Urology.

The study was funded by the Department of Veterans Affairs, the National Institutes of Health, the Georgia Cancer Coalition and the American Urological Association Foundation.

Prostate cancer is the second most common cancer, following skin cancer, in men in the United States, and a man has a one-in-six chance of being diagnosed with prostate cancer at some point during his life, according to the Prostate Cancer Foundation. Obese men diagnosed with the disease are 20 percent more likely to die from it than men of healthy weight.

Doctors typically conduct a biopsy when cancer is indicated by screening tests, such as a blood test for PSA, or by an irregular finding on a digital rectal exam. To perform a biopsy, a physician inserts a needle into the prostate and removes tissue for analysis.

In the study, the researchers analyzed data on more than 1,100 men who underwent surgery between 1996 and 2005 to remove the prostate gland, a common treatment for prostate cancer. They compared the aggressiveness of each patient’s cancer as suggested by examination of samples obtained during diagnostic biopsy with the actual aggressiveness of disease found by microscopic examination of the diseased prostate tissue removed at the time of surgery.

Obese men were 89 percent more likely than healthy weight men to have a more aggressive form of prostate cancer than was indicated by biopsy, Freedland said. Men with a body mass index (BMI) greater than 30 are considered obese. BMI is a measurement of weight adjusted for height. On this scale, a five-foot, 11-inch man weighing more than 215 pounds would be obese.

The researchers also found that men who were overweight but not obese were 44 percent more likely to have aggressive cancers than suggested by biopsy. Men with a body mass index between 25 and 29.9 are considered overweight; a five-foot, 11-inch man weighting more than 180 pounds would be overweight.

Freedland said the reasons for the discrepancies are unclear, but could be related to the fact that obese and overweight men have larger-sized prostates, which could mean that the usual number of samples taken during a biopsy is insufficient to reveal the gland’s actual status.

To help reduce the number of obese men whose prostate cancers are incorrectly classified, doctors should conduct biopsies on more areas of the prostate gland, Freedland said.

"Performing more biopsy samples will help determine the true aggressiveness of the prostate cancer and will allow treatment to be better tailored to the patients’ needs," he said

Lauren Shaftel | EurekAlert!
Further information:
http://www.duke.edu

More articles from Health and Medicine:

nachricht Second cause of hidden hearing loss identified
20.02.2017 | Michigan Medicine - University of Michigan

nachricht Prospect for more effective treatment of nerve pain
20.02.2017 | Universität Zürich

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Switched-on DNA

20.02.2017 | Materials Sciences

Second cause of hidden hearing loss identified

20.02.2017 | Health and Medicine

Prospect for more effective treatment of nerve pain

20.02.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>